You are here

biologics

Biologics to overtake small molecules in solid tumors treatment by 2027

Biologics to overtake small molecules in solid tumors treatment by 2027

Biopharma Reporter

small molecule drugs

Flag link:

What’s Next In Biologics? Biosimilar Expert Predicts Big Fall Changes

What’s Next In Biologics? Biosimilar Expert Predicts Big Fall Changes

Forbes

Flag link:

IRA Creates Unintended Complications for Biologics

IRA Creates Unintended Complications for Biologics

BioSpace

Inflation Reduction Act

Flag link:

Kodiak Sciences Scraps Late-Stage Vision Loss Biologic

Kodiak Sciences Scraps Late-Stage Vision Loss Biologic

BioSpace

Kodiak Sciences

diabetic macular edema

tarcocimab tedromer

Flag link:

Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices

Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices

BioSpace

Teva Pharmaceutical

Flag link:

TORL BioTherapeutics launches with $158M to target cancer

TORL BioTherapeutics launches with $158M to target cancer

Labiotech.eu

TORL BioTherapeutics

Flag link:

Genentech turns out lights at first commercial biologics plant, laying off 265 staffers

Genentech turns out lights at first commercial biologics plant, laying off 265 staffers

Fierce Pharma

Flag link:

FDA plans to launch communications pilot for promising rare disease gene therapies

FDA plans to launch communications pilot for promising rare disease gene therapies

RAPS.org

Flag link:

Genentech's California biologics facility will support launches in cancer, neuroscience and more: exec

Genentech's California biologics facility will support launches in cancer, neuroscience and more: exec

Fierce Pharma

drug manufacturing

Flag link:

GSK, Sanofi, Takeda sign with Singapore partnership to advance biologic manufacturing

GSK, Sanofi, Takeda sign with Singapore partnership to advance biologic manufacturing

Fierce Pharma

Flag link:

A biologic’s efficacy in a pill: Dice posts first human data for oral psoriasis med

A biologic’s efficacy in a pill: Dice posts first human data for oral psoriasis med

MedCity News

DiCE Therapeutics

Flag link:

Novartis investing US$300m in next generation biotherapeutics development

Novartis investing US$300m in next generation biotherapeutics development

Biopharma Reporter

biotherapeutics

drug development

Flag link:

Novartis funnels $300M into early biologic drug manufacturing

Novartis funnels $300M into early biologic drug manufacturing

BioPharma Dive

drug manufacturing

Flag link:

Horizon charts massive biologics expansion in Ireland, where it'll add 350 new jobs

Horizon charts massive biologics expansion in Ireland, where it'll add 350 new jobs

Fierce Pharma

drug manufacturing

Flag link:

Catalent buys partially built biologics plant with plans to shell out $160M to finish it

Catalent buys partially built biologics plant with plans to shell out $160M to finish it

Fierce Pharma

drug manufacturing

Flag link:

Catalent completes $30m expansion to biologics network

Catalent completes $30m expansion to biologics network

Biopharma Reporter

drug manufacturing

Flag link:

J&J's long-acting injectable push barrels forward as it adds 2nd large molecule to Midatech pact

J&J's long-acting injectable push barrels forward as it adds 2nd large molecule to Midatech pact

Fierce Biotech

Flag link:

Recipharm grows biologics business as it acquires Arranta Bio and Vibalogics

Recipharm grows biologics business as it acquires Arranta Bio and Vibalogics

Biopharma Reporter

Flag link:

Biologics CDMO market is expanding rapidly but is challenged by capacity constraints

Biologics CDMO market is expanding rapidly but is challenged by capacity constraints

Biopharma Reporter

Flag link:

Eli Lilly plans €400m Irish plant that will create 800 jobs

Eli Lilly plans €400m Irish plant that will create 800 jobs

Pharmaforum

drug manufacturing

Flag link:

Pages